207 related articles for article (PubMed ID: 33704724)
1. Immunoaffinity-Based Isolation of Melanoma Cell-Derived and T Cell-Derived Exosomes from Plasma of Melanoma Patients.
Mondal SK; Whiteside TL
Methods Mol Biol; 2021; 2265():305-321. PubMed ID: 33704724
[TBL] [Abstract][Full Text] [Related]
2. Immunoaffinity-based isolation of melanoma cell-derived exosomes from plasma of patients with melanoma.
Sharma P; Ludwig S; Muller L; Hong CS; Kirkwood JM; Ferrone S; Whiteside TL
J Extracell Vesicles; 2018; 7(1):1435138. PubMed ID: 29511460
[TBL] [Abstract][Full Text] [Related]
3. Proteomic profile of melanoma cell-derived small extracellular vesicles in patients' plasma: a potential correlate of melanoma progression.
Pietrowska M; Zebrowska A; Gawin M; Marczak L; Sharma P; Mondal S; Mika J; Polańska J; Ferrone S; Kirkwood JM; Widlak P; Whiteside TL
J Extracell Vesicles; 2021 Feb; 10(4):e12063. PubMed ID: 33613873
[TBL] [Abstract][Full Text] [Related]
4. Immunosuppressive functions of melanoma cell-derived exosomes in plasma of melanoma patients.
Whiteside TL
Front Cell Dev Biol; 2022; 10():1080925. PubMed ID: 36684448
[TBL] [Abstract][Full Text] [Related]
5. Signaling of Tumor-Derived sEV Impacts Melanoma Progression.
Zebrowska A; Widlak P; Whiteside T; Pietrowska M
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32709086
[TBL] [Abstract][Full Text] [Related]
6. Melanoma cell-derived exosomes in plasma of melanoma patients suppress functions of immune effector cells.
Sharma P; Diergaarde B; Ferrone S; Kirkwood JM; Whiteside TL
Sci Rep; 2020 Jan; 10(1):92. PubMed ID: 31919420
[TBL] [Abstract][Full Text] [Related]
7. Tumor-Derived Exosomes (TEX) and Their Role in Immuno-Oncology.
Whiteside TL; Diergaarde B; Hong CS
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207762
[TBL] [Abstract][Full Text] [Related]
8. Evaluating tumor cell- and T cell-derived extracellular vesicles as potential biomarkers of cancer and immune cell competence.
Whiteside TL
Expert Rev Mol Diagn; 2023 Feb; 23(2):109-122. PubMed ID: 36787282
[TBL] [Abstract][Full Text] [Related]
9. The potential role of tumor-derived exosomes in diagnosis, prognosis, and response to therapy in cancer.
Czystowska-Kuzmicz M; Whiteside TL
Expert Opin Biol Ther; 2021 Feb; 21(2):241-258. PubMed ID: 32813990
[TBL] [Abstract][Full Text] [Related]
10. The potential of tumor-derived exosomes for noninvasive cancer monitoring: an update.
Whiteside TL
Expert Rev Mol Diagn; 2018 Dec; 18(12):1029-1040. PubMed ID: 30406709
[No Abstract] [Full Text] [Related]
11. CD44v3 protein-carrying tumor-derived exosomes in HNSCC patients' plasma as potential noninvasive biomarkers of disease activity.
Theodoraki MN; Matsumoto A; Beccard I; Hoffmann TK; Whiteside TL
Oncoimmunology; 2020; 9(1):1747732. PubMed ID: 32313730
[TBL] [Abstract][Full Text] [Related]
12. Circulating exosomes measure responses to therapy in head and neck cancer patients treated with cetuximab, ipilimumab, and IMRT.
Theodoraki MN; Yerneni S; Gooding WE; Ohr J; Clump DA; Bauman JE; Ferris RL; Whiteside TL
Oncoimmunology; 2019; 8(7):1593805. PubMed ID: 31143513
[No Abstract] [Full Text] [Related]
13. Challenges in Exosome Isolation and Analysis in Health and Disease.
Ludwig N; Whiteside TL; Reichert TE
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31546622
[TBL] [Abstract][Full Text] [Related]
14. The Role of Melanoma Cell-Derived Exosomes (MTEX) and Photodynamic Therapy (PDT) within a Tumor Microenvironment.
Mkhobongo B; Chandran R; Abrahamse H
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575889
[TBL] [Abstract][Full Text] [Related]
15. Isolation and Analysis of Tumor-Derived Exosomes.
Ludwig N; Hong CS; Ludwig S; Azambuja JH; Sharma P; Theodoraki MN; Whiteside TL
Curr Protoc Immunol; 2019 Dec; 127(1):e91. PubMed ID: 31763776
[TBL] [Abstract][Full Text] [Related]
16. The potential of tumor-derived exosomes for noninvasive cancer monitoring.
Whiteside TL
Expert Rev Mol Diagn; 2015; 15(10):1293-310. PubMed ID: 26289602
[TBL] [Abstract][Full Text] [Related]
17. Proteomic profiles of melanoma cell-derived exosomes in plasma: discovery of potential biomarkers of melanoma progression.
Mondal SK; Whiteside TL
Melanoma Res; 2021 Oct; 31(5):472-475. PubMed ID: 34284459
[TBL] [Abstract][Full Text] [Related]
18. Isolation of Biologically Active Exosomes from Plasma of Patients with Cancer.
Hong CS; Funk S; Whiteside TL
Methods Mol Biol; 2017; 1633():257-265. PubMed ID: 28735492
[TBL] [Abstract][Full Text] [Related]
19. Separation of plasma-derived exosomes into CD3
Theodoraki MN; Hoffmann TK; Whiteside TL
Clin Exp Immunol; 2018 Jun; 192(3):271-283. PubMed ID: 29431869
[TBL] [Abstract][Full Text] [Related]
20. Proteomic and Metabolomic Profiles of T Cell-Derived Exosomes Isolated from Human Plasma.
Zebrowska A; Jelonek K; Mondal S; Gawin M; Mrowiec K; Widłak P; Whiteside T; Pietrowska M
Cells; 2022 Jun; 11(12):. PubMed ID: 35741093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
